SEC-sourced researchBeta
BIAFW
bioAffinity Technologies, Inc.
Company comparison ↗
Data passport
- CIK
- 0001712762
- Exchange
- Nasdaq
- Business activity
- Services-Commercial Physical & Biological Research · SIC 8731
- Financial inputs
- 6/6
- Filing date
- Nov 20, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 9,362,022.0000 | Mar 16, 2026 |
| December 2025 | 6,161,959.0000 | Mar 16, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 6,161,959.0000 | -14,909,754.0000 | -9,328,842.0000 | 10,960,772.0000 | 3,683,116.0000 | Mar 16, 2026 |
| December 2024 | 9,362,022.0000 | -9,039,831.0000 | -7,264,795.0000 | 6,513,667.0000 | 3,911,631.0000 | Mar 16, 2026 |
Explainable fundamental score
Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.
36/100
Profitability0
Growth16
Balance sheet66
Cash generation0
Data coverage100
Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $6.16M | Jan 1, 2025 – Dec 31, 2025 | Mar 16, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $9.36M | Jan 1, 2024 – Dec 31, 2024 | Mar 16, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$14.91M | Jan 1, 2025 – Dec 31, 2025 | Mar 16, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$9.33M | Jan 1, 2025 – Dec 31, 2025 | Mar 16, 2026 | 10-K |
| Total assetsAssets | $10.96M | Dec 31, 2025 | Mar 16, 2026 | 10-K |
| Total liabilitiesLiabilities | $3.68M | Dec 31, 2025 | Mar 16, 2026 | 10-K |
New filings
- 8-KBIAFW · bioAffinity Technologies, Inc.Nov 20, 2026 · Current event
- S-1BIAFW · bioAffinity Technologies, Inc.Nov 20, 2026 · Other
- 8-KBIAFW · bioAffinity Technologies, Inc.Nov 19, 2026 · Current event
- SCHEDULE 13GBIAFW · bioAffinity Technologies, Inc.Nov 19, 2026 · Other
- 4BIAFW · bioAffinity Technologies, Inc.Nov 19, 2026 · Other
- 3BIAFW · bioAffinity Technologies, Inc.Nov 19, 2026 · Other
- 8-KBIAFW · bioAffinity Technologies, Inc.Nov 17, 2026 · Current event
- 8-KBIAFW · bioAffinity Technologies, Inc.Nov 6, 2026 · Current event
- 10-QBIAFW · bioAffinity Technologies, Inc.Nov 6, 2026 · Periodic
- 424B5BIAFW · bioAffinity Technologies, Inc.Nov 3, 2026 · Other
- 424B5BIAFW · bioAffinity Technologies, Inc.Nov 2, 2026 · Other
- 8-KBIAFW · bioAffinity Technologies, Inc.Oct 29, 2026 · Current event
- DEF 14ABIAFW · bioAffinity Technologies, Inc.Oct 23, 2026 · Other
- 8-KBIAFW · bioAffinity Technologies, Inc.Oct 15, 2026 · Current event
- 8-KBIAFW · bioAffinity Technologies, Inc.Oct 13, 2026 · Current event
- PRER14ABIAFW · bioAffinity Technologies, Inc.Oct 13, 2026 · Other
- 8-KBIAFW · bioAffinity Technologies, Inc.Oct 9, 2026 · Current event
- 424B5BIAFW · bioAffinity Technologies, Inc.Oct 9, 2026 · Other
- 424B5BIAFW · bioAffinity Technologies, Inc.Oct 9, 2026 · Other
- 8-KBIAFW · bioAffinity Technologies, Inc.Oct 8, 2026 · Current event